Literature DB >> 33323514

Neonatal Mouse Gut Metabolites Influence Cryptosporidium parvum Infection in Intestinal Epithelial Cells.

Kelli L VanDussen1, Lisa J Funkhouser-Jones2, Marianna E Akey2, Deborah A Schaefer3, Kevin Ackman3, Michael W Riggs3, Thaddeus S Stappenbeck1, L David Sibley4.   

Abstract

The protozoan parasite Cryptosporidium sp. is a leading cause of diarrheal disease in those with compromised or underdeveloped immune systems, particularly infants and toddlers in resource-poor localities. As an enteric pathogen, Cryptosporidium sp. invades the apical surface of intestinal epithelial cells, where it resides in close proximity to metabolites in the intestinal lumen. However, the effect of gut metabolites on susceptibility to Cryptosporidium infection remains largely unstudied. Here, we first identified which gut metabolites are prevalent in neonatal mice when they are most susceptible to Cryptosporidium parvum infection and then tested the isolated effects of these metabolites on C. parvum invasion and growth in intestinal epithelial cells. Our findings demonstrate that medium or long-chain saturated fatty acids inhibit C. parvum growth, perhaps by negatively affecting the streamlined metabolism in C. parvum, which is unable to synthesize fatty acids. Conversely, long-chain unsaturated fatty acids enhanced C. parvum invasion, possibly by modulating membrane fluidity. Hence, gut metabolites, either from diet or produced by the microbiota, influence C. parvum growth in vitro and may also contribute to the early susceptibility to cryptosporidiosis seen in young animals.IMPORTANCE Cryptosporidium sp. occupies a unique intracellular niche that exposes the parasite to both host cell contents and the intestinal lumen, including metabolites from the diet and produced by the microbiota. Both dietary and microbial products change over the course of early development and could contribute to the changes seen in susceptibility to cryptosporidiosis in humans and mice. Consistent with this model, we show that the immature gut metabolome influenced the growth of Cryptosporidium parvum in vitro Interestingly, metabolites that significantly altered parasite growth were fatty acids, a class of molecules that Cryptosporidium sp. is unable to synthesize de novo The enhancing effects of polyunsaturated fatty acids and the inhibitory effects of saturated fatty acids presented in this study may provide a framework for future studies into this enteric parasite's interactions with exogenous fatty acids during the initial stages of infection.
Copyright © 2020 VanDussen et al.

Entities:  

Keywords:  16S rRNA; Cryptosporidium parvum; enteric infection; essential nutrient; fatty acid; metabolite; microbiota

Year:  2020        PMID: 33323514      PMCID: PMC7773987          DOI: 10.1128/mBio.02582-20

Source DB:  PubMed          Journal:  mBio            Impact factor:   7.867


  66 in total

1.  A Weaning Reaction to Microbiota Is Required for Resistance to Immunopathologies in the Adult.

Authors:  Ziad Al Nabhani; Sophie Dulauroy; Rute Marques; Clara Cousu; Shahed Al Bounny; François Déjardin; Tim Sparwasser; Marion Bérard; Nadine Cerf-Bensussan; Gérard Eberl
Journal:  Immunity       Date:  2019-03-19       Impact factor: 31.745

Review 2.  The Burden and Etiology of Diarrheal Illness in Developing Countries.

Authors:  Karen L Kotloff
Journal:  Pediatr Clin North Am       Date:  2017-08       Impact factor: 3.278

3.  Neutralization-sensitive epitopes are exposed on the surface of infectious Cryptosporidium parvum sporozoites.

Authors:  M W Riggs; T C McGuire; P H Mason; L E Perryman
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

Review 4.  Cryptosporidium: a water-borne zoonotic parasite.

Authors:  Ronald Fayer
Journal:  Vet Parasitol       Date:  2004-12-09       Impact factor: 2.738

5.  The genome of Cryptosporidium hominis.

Authors:  Ping Xu; Giovanni Widmer; Yingping Wang; Luiz S Ozaki; Joao M Alves; Myrna G Serrano; Daniela Puiu; Patricio Manque; Donna Akiyoshi; Aaron J Mackey; William R Pearson; Paul H Dear; Alan T Bankier; Darrell L Peterson; Mitchell S Abrahamsen; Vivek Kapur; Saul Tzipori; Gregory A Buck
Journal:  Nature       Date:  2004-10-28       Impact factor: 49.962

6.  Cryptosporidium parvum-Infected Neonatal Mice Show Gut Microbiota Remodelling Using High-Throughput Sequencing Analysis: Preliminary Results.

Authors:  Mohamed Mammeri; Aurélie Chevillot; Myriam Thomas; Christine Julien; Eric Auclair; Thomas Pollet; Bruno Polack; Isabelle Vallée; Karim Tarik Adjou
Journal:  Acta Parasitol       Date:  2019-03-26       Impact factor: 1.440

7.  The reductase domain in a Type I fatty acid synthase from the apicomplexan Cryptosporidium parvum: restricted substrate preference towards very long chain fatty acyl thioesters.

Authors:  Guan Zhu; Xiangyu Shi; Xiaomin Cai
Journal:  BMC Biochem       Date:  2010-11-22       Impact factor: 4.059

8.  Differential Gene Expression and Protein Localization of Cryptosporidium parvum Fatty Acyl-CoA Synthetase Isoforms.

Authors:  Fengguang Guo; Haili Zhang; Harold Ross Payne; Guan Zhu
Journal:  J Eukaryot Microbiol       Date:  2015-10-19       Impact factor: 3.346

9.  MetaboAnalyst 3.0--making metabolomics more meaningful.

Authors:  Jianguo Xia; Igor V Sinelnikov; Beomsoo Han; David S Wishart
Journal:  Nucleic Acids Res       Date:  2015-04-20       Impact factor: 16.971

10.  Development of a primary mouse intestinal epithelial cell monolayer culture system to evaluate factors that modulate IgA transcytosis.

Authors:  C Moon; K L VanDussen; H Miyoshi; T S Stappenbeck
Journal:  Mucosal Immunol       Date:  2013-11-13       Impact factor: 7.313

View more
  8 in total

1.  Effect of Caging on Cryptosporidium parvum Proliferation in Mice.

Authors:  Hannah N Creasey; Wen Zhang; Giovanni Widmer
Journal:  Microorganisms       Date:  2022-06-17

Review 2.  Polymicrobial Interactions Operative during Pathogen Transmission.

Authors:  Hannah M Rowe; Jason W Rosch
Journal:  mBio       Date:  2021-05-18       Impact factor: 7.867

Review 3.  Cryptosporidium: Host-Parasite Interactions and Pathogenesis.

Authors:  Derek J Pinto; Sumiti Vinayak
Journal:  Curr Clin Microbiol Rep       Date:  2021-02-08

4.  Development of Two Mouse Models for Vaccine Evaluation against Cryptosporidiosis.

Authors:  Denise Ann Dayao; Justyna Jaskiewcz; Sangun Lee; Bruno Cesar Oliveira; Abhineet Sheoran; Giovanni Widmer; Saul Tzipori
Journal:  Infect Immun       Date:  2022-06-23       Impact factor: 3.609

5.  Lentinan -triggered butyrate-producing bacteria drive the expulsion of the intestinal helminth Trichinella spiralis in mice.

Authors:  Xuemin Jin; Yi Liu; Isabelle Vallee; Gregory Karadjian; Mingyuan Liu; Xiaolei Liu
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

6.  Cryptosporidiosis Modulates the Gut Microbiome and Metabolism in a Murine Infection Model.

Authors:  Avinash V Karpe; Melanie L Hutton; Steven J Mileto; Meagan L James; Chris Evans; Rohan M Shah; Amol B Ghodke; Katie E Hillyer; Suzanne S Metcalfe; Jian-Wei Liu; Tom Walsh; Dena Lyras; Enzo A Palombo; David J Beale
Journal:  Metabolites       Date:  2021-06-11

7.  Serum metabolomics in chickens infected with Cryptosporidium baileyi.

Authors:  Xue-Mei Wu; Xin Yang; Xian-Cheng Fan; Xi Chen; Yu-Xin Wang; Long-Xian Zhang; Jun-Ke Song; Guang-Hui Zhao
Journal:  Parasit Vectors       Date:  2021-06-26       Impact factor: 3.876

8.  Developmental Stage, Solid Food Introduction, and Suckling Cessation Differentially Influence the Comaturation of the Gut Microbiota and Intestinal Epithelium in Rabbits.

Authors:  Martin Beaumont; Eloïse Mussard; Céline Barilly; Corinne Lencina; Laure Gress; Louise Painteaux; Béatrice Gabinaud; Laurent Cauquil; Patrick Aymard; Cécile Canlet; Charlotte Paës; Christelle Knudsen; Sylvie Combes
Journal:  J Nutr       Date:  2022-03-03       Impact factor: 4.798

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.